What You Need to Know
On September 13, 2019, the FDA announced that preliminary tests found low levels of the environmental contaminant NDMA in ranitidine (Zantac.) When ingested, NDMA is a potent carcinogen linked to several forms of cancer including stomach, liver, bladder, pancreatic, and prostate cancers. In response to this warning, several retailers like CVS and Walgreens pulled Zantac and its generic ranitidine from the shelves. Finally, on April 1, 2020, the FDA ordered all Zantac and Ranitidine products off the shelf. For more information, click here
Join the Zantac Lawsuit
If you or a loved one took Zantac and were diagnosed with cancer, it is in your best interest to speak with an experienced personal injury attorney about filing a Zantac lawsuit. The attorneys at Fuicelli & Lee can help you fight for justice and compensation. Contact us today at 303-355-7202. We offer free virtual consultations.